Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’s Heart Health and Overall Health Exclusively on Amazon
WHITNEY JOHNS™ WOMEN’S CITRUS BERGAMOT WHITNEY JOHNS™ WOMEN’S CITRUS BERGAMOT Whitney Johns’ Citrus Bergamot for…
News
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
STS101 demonstrated a favorable safety and tolerability profile, consistent with clinical experience to date Over…
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
A dozen global pharmaceutical companies have joined effort to accelerate critical therapies to citizens of…
Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing
First use of Ciitizen platform as source of real-world data in regulatory filing SAN FRANCISCO…
Sofwave Participate in LifeSci Partners HealthTech Symposium
Virtual fireside chat to take place on Wednesday, September 21, 2022 at 11:00 a.m. ET…
Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™ Compositions
CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Ring Therapeutics, a life sciences company founded…
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
Advanced insights from CytoReason’s disease models will support Pfizer’s drug development process TEL AVIV, Israel,…
Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland
Reimbursement granted with no restrictions to the label ATLANTA, Sept. 20, 2022 (GLOBE NEWSWIRE) —…
Albireo to Participate in Guggenheim Nantucket Therapeutics Conference
BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease…
Applied Molecular Transport Completes Enrollment of Phase 2 LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
Top-line data readout anticipated late 2022 or early 2023 SOUTH SAN FRANCISCO, Calif., Sept. 20,…
Orchestra BioMed™ Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT™ at TCT 2022
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7…
Elicio Therapeutics Receives $2.8 Million Grant from the Gastro-Intestinal Research Foundation (GIRF) to Fund Research for Two Therapeutic Cancer Vaccines
Funds will advance research into ELI-007 as a mutant BRAF-peptide vaccine and ELI-008 as a…
Humacyte Expands Board of Directors and Leadership Team with New Appointments
Lt. General Bruce Green, M.D., USAF-ret. Joins Board of Directors Cindy Cao, Ph.D. Appointed as…
Biomea Fusion Presents New Preclinical Data at the European Association for the Study of Diabetes (EASD) Annual Meeting Describing BMF-219’s Potential as a Novel, Oral, Long-Acting Treatment for Type 2 Diabetes
Menin, a transcriptional scaffold protein, regulates pancreatic beta cell homeostasis; inhibiting menin function with BMF-219…
ImmuneSensor Awarded $16 Million Grant from the Cancer Prevention and Research Institute of Texas (CPRIT)
Award to support Phase 2 development of IMSA101, a STING agonist, in solid tumor malignancies…
Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial with Initial Results Indicating Allele-Selective Target Engagement with WVE-003 in Huntington’s Disease
Single doses of WVE-003 appear generally safe and well-tolerated CSF mutant huntingtin (mHTT) protein was…
OpGen Subsidiary Curetis and FIND Sign R&D Collaboration Agreement for Unyvero A30 RQ Platform
FIND, the global alliance for diagnostics, together with German KfW bank co-funds development of Unyvero…
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
– The first and only treatment in Europe to treat patients with molybdenum cofactor deficiency…
Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer
CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology…
Luc Debruyne Appointed as Observer to the Board of Directors of Bavarian Nordic
COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the…